Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Timolol Gel for Epistaxis in HHT
NCT04139018Phase 2Completed
- Sponsor
- Washington University School of Medicine
- Start
- Oct 2019
- Primary completion
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of timolol maleate gel + placebo in hereditary hemorrhagic telangiectasia (HHT), sponsored by Washington University School of Medicine. Started Oct 2019; status: completed.
02
Drugs
timolol maleate gel + placebo
03
Conditions
hereditary hemorrhagic telangiectasia (HHT)
Beyond the preview
Go deeper on NCT04139018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04139018.